142 related articles for article (PubMed ID: 30852384)
21. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of novel
Chen H; Qiao C; Miao TT; Li AL; Wang WY; Gu W
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1544-1561. PubMed ID: 31448648
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole-dithiocarbamate-urea hybrids.
Duan YC; Zheng YC; Li XC; Wang MM; Ye XW; Guan YY; Liu GZ; Zheng JX; Liu HM
Eur J Med Chem; 2013 Jun; 64():99-110. PubMed ID: 23644193
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells.
İbiş K; Nalbat E; Çalışkan B; Kahraman DC; Cetin-Atalay R; Banoglu E
Eur J Med Chem; 2021 Oct; 221():113489. PubMed ID: 33951549
[TBL] [Abstract][Full Text] [Related]
25. Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates bearing sulfonylpiperazine as antitumor inhibitors targeting PI3Kα.
Yin Y; Sha S; Wu X; Wang SF; Qiao F; Song ZC; Zhu HL
Eur J Med Chem; 2019 Nov; 182():111630. PubMed ID: 31446244
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.
Xie R; Li Y; Tang P; Yuan Q
Eur J Med Chem; 2018 Jan; 143():320-333. PubMed ID: 29202397
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and evaluation of novel coumarin-dithiocarbamate derivatives (IDs) as anti-colorectal cancer agents.
Zhu H; Ying S; Zhou B; Hu X; Liang X; Li W; Wang D; Jin H; Pan Y
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):593-604. PubMed ID: 33557648
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.
Buragohain P; Saikia B; Surineni N; Barua NC; Saxena AK; Suri N
Bioorg Med Chem Lett; 2014 Jan; 24(1):237-9. PubMed ID: 24332623
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anticancer activity evaluation of some benzothiazole-piperazine derivatives.
Gurdal EE; Buclulgan E; Durmaz I; Cetin-Atalay R; Yarim M
Anticancer Agents Med Chem; 2015; 15(3):382-9. PubMed ID: 25511511
[TBL] [Abstract][Full Text] [Related]
30. Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities.
Su Y; Li R; Ning X; Lin Z; Zhao X; Zhou J; Liu J; Jin Y; Yin Y
Eur J Med Chem; 2019 Sep; 177():32-46. PubMed ID: 31129452
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and cytotoxic evaluation of quinazolin-4(3H)-one derivatives bearing thiocarbamate, thiourea or N-methyldithiocarbamate side chains.
Cao SL; Xu H; Wang Y; Liao J; Zhang JJ; Li ZF; Guo YW; Li XR; Cui XM; Xu X
Med Chem; 2012 Mar; 8(2):163-73. PubMed ID: 22385175
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of artemisinin derivatives containing fluorine atoms as anticancer agents.
Li S; Li G; Yang X; Meng Q; Yuan S; He Y; Sun D
Bioorg Med Chem Lett; 2018 Jul; 28(13):2275-2278. PubMed ID: 29789258
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antitumor activity of novel dithiocarbamate substituted chromones.
Huang W; Ding Y; Miao Y; Liu MZ; Li Y; Yang GF
Eur J Med Chem; 2009 Sep; 44(9):3687-96. PubMed ID: 19410339
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.
Liu MC; Yang SJ; Jin LH; Hu DY; Xue W; Song BA; Yang S
Eur J Med Chem; 2012 Dec; 58():128-35. PubMed ID: 23124210
[TBL] [Abstract][Full Text] [Related]
35. Novel spirobicyclic artemisinin analogues (artemalogues): Synthesis and antitumor activities.
Liu G; Song S; Shu S; Miao Z; Zhang A; Ding C
Eur J Med Chem; 2015 Oct; 103():17-28. PubMed ID: 26318055
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationships of a novel class of dithiocarbamic acid esters as anticancer agent.
Hou X; Ge Z; Wang T; Guo W; Wu J; Cui J; Lai C; Li R
Arch Pharm (Weinheim); 2011 May; 344(5):320-32. PubMed ID: 21509804
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of Tamoxifen-Artemisinin and Estrogen-Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer.
Fröhlich T; Mai C; Bogautdinov RP; Morozkina SN; Shavva AG; Friedrich O; Gilbert DF; Tsogoeva SB
ChemMedChem; 2020 Aug; 15(15):1473-1479. PubMed ID: 32374071
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro antitumor activity of new butenolide-containing dithiocarbamates.
Wang XJ; Xu HW; Guo LL; Zheng JX; Xu B; Guo X; Zheng CX; Liu HM
Bioorg Med Chem Lett; 2011 May; 21(10):3074-7. PubMed ID: 21486694
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anticancer activity of novel deoxoartemisinin-glycolipid hybrids.
Min D; Kim M; Ricci J; Jung S; Kim K; Chung WY; Park KK; Jung M
Chem Pharm Bull (Tokyo); 2014; 62(5):446-53. PubMed ID: 24614158
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of formononetin-dithiocarbamate hybrids that inhibit growth and migration of PC-3 cells via MAPK/Wnt signaling pathways.
Fu DJ; Zhang L; Song J; Mao RW; Zhao RH; Liu YC; Hou YH; Li JH; Yang JJ; Jin CY; Li P; Zi XL; Liu HM; Zhang SY; Zhang YB
Eur J Med Chem; 2017 Feb; 127():87-99. PubMed ID: 28038329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
